Science Explorer Back to mapMap

Most cited papers from Vichem Chemie (Hungary)

What are the most cited papers from Vichem Chemie (Hungary)?

The most cited paper from Vichem Chemie (Hungary) is "Kinase-Selective Enrichment Enables Quantitative Phosphoproteomics of the Kinome across the Cell Cycle" (Henrik Daub, Jesper Velgaard Olsen, Michaela Bairlein et al., 2008), with 612 citations. Next come "Large-scale Proteomics Analysis of the Human Kinome" (294) and "Cellular Targets of Gefitinib" (242).

Showing 50 of 60 papers. Every paper with more than 22 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Kinase-Selective Enrichment Enables Quantitative Phosphoproteomics of the Kinome across the Cell Cycle Henrik Daub, Jesper Velgaard Olsen, Michaela Bairlein et al. · Molecular Cell Open access Aug 2008 612
2 Large-scale Proteomics Analysis of the Human Kinome Felix S. Oppermann, Florian Gnad, Jesper Velgaard Olsen et al. · Molecular & Cellular Proteomics Open access 15 Apr 2009 294
3 Cellular Targets of Gefitinib Dirk Brehmer, Zoltán Greff, Klaus Godl et al. · Cancer Research Open access 15 Jan 2005 242
4 AXL Is a Potential Target for Therapeutic Intervention in Breast Cancer Progression Yi-xiang Zhang, Peter G. Knyazev, Yu. V. Cheburkin et al. · Cancer Research 13 Mar 2008 211
5 Small Molecule Inhibition of ERK Dimerization Prevents Tumorigenesis by RAS-ERK Pathway Oncogenes Ana Herrero et al. · Cancer Cell Open access Aug 2015 154
6 Proteomics strategy for quantitative protein interaction profiling in cell extracts Kirti Sharma, Christoph K. Weber, Michaela Bairlein et al. · Nature Methods 13 Sep 2009 149
7 Characterization of a Conserved Structural Determinant Controlling Protein Kinase Sensitivity to Selective Inhibitors Stephanie Blencke, Birgit Zech, Ola Engkvist et al. · Chemistry & Biology Open access May 2004 143
8 NADPH Oxidase 4 Is Expressed in Pulmonary Artery Adventitia and Contributes to Hypertensive Vascular Remodeling Scott A. Barman et al. · Arteriosclerosis Thrombosis and Vascular Biology Open access 20 Jun 2014 119
9 Proteomics Analysis of Protein Kinases by Target Class-selective Prefractionation and Tandem Mass Spectrometry Josef B. Wissing, Lothar Jänsch, Manfred Nimtz et al. · Molecular & Cellular Proteomics Open access 27 Dec 2006 112
10 Leads for antitubercular compounds from kinase inhibitor library screens Sophie Magnet, Ruben Christiaan Hartkoorn, Rita Székely et al. · Tuberculosis Open access 13 Oct 2010 105
11 Anticytolytic Screen Identifies Inhibitors of Mycobacterial Virulence Protein Secretion Jan Rybniker, Jeffrey M. Chen, Claudia Corina Sala et al. · Cell Host & Microbe Open access Oct 2014 102
12 The Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for Tuberculosis Vinayak Singh et al. · ACS Infectious Diseases Open access 30 Aug 2016 101
13 Metformin Attenuates Palmitate-Induced Endoplasmic Reticulum Stress, Serine Phosphorylation of IRS-1 and Apoptosis in Rat Insulinoma Cells Laura Simon‐Szabó, Márton Kokas, József Mandl et al. · PLoS ONE Open access 4 Jun 2014 94
14 TP53 mutation‐correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53‐mutated breast cancers Balázs Győrffy, Giulia Bottai, Jacqueline Lehmann‐Che et al. · Molecular Oncology Open access 5 Jan 2014 89
15 Complex regulation of autophagy in cancer – Integrated approaches to discover the networks that hold a double-edged sword János Kubisch, Dénes Türei, László Földvári-Nagy et al. · Seminars in Cancer Biology 28 Jun 2013 87
16 Synthesis and Evaluation of Phosphorus Containing, Specific CDK9/CycT1 Inhibitors Gabor G. Nemeth, Zoltán Greff, Anna Sipos et al. · Journal of Medicinal Chemistry Open access 17 Apr 2014 81
17 A novel drug discovery concept for tuberculosis: Inhibition of bacterial and host cell signalling Rita Székely, Frigyes Wáczek, István Szabadkai et al. · Immunology Letters Open access 7 Feb 2008 77
18 Interaction of the EGFR inhibitors gefitinib, vandetanib, pelitinib and neratinib with the ABCG2 multidrug transporter: Implications for the emergence and reversal of cancer drug resistance Csilla Hegedüs, Krisztina Truta-Feles, Géza Antalffy et al. · Biochemical Pharmacology 21 Apr 2012 76
19 Gremlin regulates renal inflammation via the vascular endothelial growth factor receptor 2 pathway Carolina Lavoz, Matilde Alique, Raquel Rodrigues‐Díez et al. · The Journal of Pathology 24 Mar 2015 71
20 Connective tissue growth factor is a new ligand of epidermal growth factor receptor Sandra Rayego‐Mateos, Raquel Rodrigues‐Díez, José Luis Morgado‐Pascual et al. · Journal of Molecular Cell Biology Open access 8 Aug 2013 66
21 Integrating molecular diagnostics into anticancer drug discovery István Peták, Richard E. Schwab, László Őrfi et al. · Nature Reviews Drug Discovery Review 7 Jun 2010 61
22 Systematic Kinase Inhibitor Profiling Identifies CDK9 as a Synthetic Lethal Target in NUT Midline Carcinoma Johannes Brägelmann et al. · Cell Reports Open access Sep 2017 56
23 Small-Molecule Inhibitors of NADPH Oxidase 4 Gábor Borbély, István Szabadkai, Zoltán Horváth et al. · Journal of Medicinal Chemistry Open access 23 Aug 2010 55
24 TWEAK transactivation of the epidermal growth factor receptor mediates renal inflammation Sandra Rayego‐Mateos, José Luis Morgado‐Pascual, Ana Belen Sanz et al. · The Journal of Pathology 26 Aug 2013 53
25 How Förster Resonance Energy Transfer Imaging Improves the Understanding of Protein Interaction Networks in Cancer Biology Gilbert O. Fruhwirth, Luis P. Fernandes, Gregory E. Weitsman et al. · ChemPhysChem 15 Feb 2011 52
26 Signal Transduction Therapy with Rationally Designed Kinase Inhibitors Gÿorgý Kéri, László Őrfi, Dániel Erös et al. · Current Signal Transduction Therapy 2006 49
27 The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients Muireann Kelleher, Gilbert O. Fruhwirth, Gargi Surendra Patel et al. · Targeted Oncology Open access Sep 2009 49
28 Katalysierte Dehalogenierungen mit Natriumborhydrid Robert A. Egli · Helvetica Chimica Acta 31 Oct 1968 46
29 Design and synthesis of new imidazo[1,2- a ]pyridine and imidazo[1,2- a ]pyrazine derivatives with antiproliferative activity against melanoma cells Rita Garamvölgyi, Judit Dobos, Anna Sipos et al. · European Journal of Medicinal Chemistry Open access 17 Dec 2015 41
30 Comparison of Predictive Ability of Water Solubility QSPR Models Generated by MLR, PLS and ANN Methods Dániel Erös, Gÿorgý Kéri, István Kövesdi et al. · Mini-Reviews in Medicinal Chemistry Feb 2004 41
31 Activation of HER3 Interferes with Antitumor Effects of Axl Receptor Tyrosine Kinase Inhibitors: Suggestion of Combination Therapy Robert Torka, Kinga Pénzes, Simone Gusenbauer et al. · Neoplasia Open access Apr 2014 40
32 Improved, High Yield Synthesis of 3H-Quinazolin-4-ones, the Key Intermediates of Recently Developed Drugs László Őrfi, Frigyes Wáczek, János Pató et al. · Current Medicinal Chemistry Oct 2004 39
33 Targeting of a platinum-bound sunitinib analog to renal proximal tubular cells Robbert J. Kok, Dolman, Harmsen et al. · International Journal of Nanomedicine Open access 2012 39
34 The C-Terminal Module IV of Connective Tissue Growth Factor, Through EGFR/Nox1 Signaling, Activates the NF-κB Pathway and Proinflammatory Factors in Vascular Smooth Muscle Cells Raúl R. Rodrigues-Díez, Ana B. García‐Redondo, Macarena Orejudo et al. · Antioxidants and Redox Signaling Open access 27 Jul 2014 38
35 An Integrated Phosphoproteomics Work Flow Reveals Extensive Network Regulation in Early Lysophosphatidic Acid Signaling Thiemo B. Schreiber, Nina Mäusbacher, Gÿorgý Kéri et al. · Molecular & Cellular Proteomics Open access 13 Jan 2010 38
36 Quantitative Analysis of Kinase-Proximal Signaling in Lipopolysaccharide-Induced Innate Immune Response Kirti Sharma, Chanchal Kumar, Gÿorgý Kéri et al. · Journal of Proteome Research 12 Mar 2010 38
37 Novel compounds with potent CDK9 inhibitory activity for the treatment of myeloma Zsófia Czudor, Mária Balogh, Péter Bánhegyi et al. · Bioorganic & Medicinal Chemistry Letters Open access 2 Jan 2018 37
38 The Inflammatory Kinase MAP4K4 Promotes Reactivation of Kaposi's Sarcoma Herpesvirus and Enhances the Invasiveness of Infected Endothelial Cells Darya A. Haas, Kiran Bala, Guntram Büsche et al. · PLoS Pathogens Open access 7 Nov 2013 37
39 Signalling Inhibitors Against Mycobacterium tuberculosis – Early Days of a New Therapeutic Concept in Tuberculosis Bálint Hegymegi-Barakonyi et al. · Current Medicinal Chemistry 30 Oct 2008 36
40 Inhibition of c-Met with the Specific Small Molecule Tyrosine Kinase Inhibitor SU11274 Decreases Growth and Metastasis Formation of Experimental Human Melanoma István Kenessey, Tália Magdolna Keszthelyi, Zachary B. Kramer et al. · Current Cancer Drug Targets 27 Apr 2010 35
41 Regulation of influenza A virus mRNA splicing by CLK1 Anita Artarini et al. · Antiviral Research Open access 6 Jun 2019 34
42 Inhibition of epidermal growth factor receptor improves antitumor efficacy of vemurafenib in BRAF-mutant human melanoma in preclinical model István Kenessey, Zsófia Kramer, Lilla István et al. · Melanoma Research 20 Aug 2018 34
43 Identification of aminopyrimidine‐sulfonamides as potent modulators of Wag31‐mediated cell elongation in mycobacteria Vinayak Singh et al. · Molecular Microbiology Open access 28 Sep 2016 33
44 Novel, Selective CDK9 Inhibitors for the Treatment of HIV Infection Gabor G. Nemeth, Zoltán Varga, Zoltán Greff et al. · Current Medicinal Chemistry 2011 33
45 Drug Discovery in the Kinase Inhibitory Field Using the Nested Chemical Library™ Technology Gÿorgý Kéri et al. · Assay and Drug Development Technologies Oct 2005 33
46 Imatinib-ULS-lysozyme: A proximal tubular cell-targeted conjugate of imatinib for the treatment of renal diseases M. Emmy M. Dolman, Kim M. A. van Dorenmalen, E. Pieters et al. · Journal of Controlled Release 6 Sep 2011 33
47 Lead selection and characterization of antitubercular compounds using the Nested Chemical Library Anna Sipos, János Pató, Rita Székely et al. · Tuberculosis Open access 28 Feb 2015 31
48 Synthesis of selective SRPK-1 inhibitors: Novel tricyclic quinoxaline derivatives Zsolt Székelyhidi, János Pató, Frigyes Wáczek et al. · Bioorganic & Medicinal Chemistry Letters Open access Jun 2005 30
49 Optimization of Sirius Red-Based Microplate Assay to Investigate Collagen Production In Vitro Csenge Szász, Domonkos Pap, Beáta Szebeni et al. · International Journal of Molecular Sciences Open access 13 Dec 2023 29
50 Targeted drug combination therapy design based on driver genes Lilian Zsákai, Anna Sipos, Judit Dobos et al. · Oncotarget Open access 3 Sep 2019 29

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.